A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.

被引：14
|
作者：
Tamberi, Stefano
Grassi, Elisa
Corbelli, Jody
Papiani, Giorgio
Barbera, Maria Aurelia
Zingaretti, Chiara
Moretti, Chiara Carli
Montroni, Isacco
Petracci, Elisabetta
Caruso, Dora
Nosseir, Sofia
Nanni, Oriana
Frassineti, Giovanni Luca
Di Bartolomeo, Maria
Marzola, Marina
Bonetti, Andrea
Gelsomino, Fabio
Pinto, Carmine
Tassinari, Davide
Ugolini, Giampaolo
机构：
[1] Ospedale Gli Infermi, Faenza, Italy
[2] Infermi Hosp, Faenza, Italy
[3] IRCCS, IRST Meldola, Unita Biostat & Sperimentazioni Clin, Ravenna, Italy
[4] Infermi Hosp, Faenza, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Biostat & Clin Trials, Meldola, Italy
[6] Ravenna Hosp, Dept Pathol, Ravenna, Italy
[7] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCSS, Meldola, Italy
[8] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCSS, Med Oncol Unit, Meldola, Italy
[9] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[10] Univ Ferrara, Ferrara, Italy
[11] Mater Salutis Hosp, Dept Med Oncol, Legnago, Italy
[12] Univ Hosp Modena, Modena, Italy
[13] AUSL IRCCS Reggio Emilia, Med Oncol Unit, Clin Canc Ctr, Reggio Emilia, Italy
[14] Dept Oncol, Rimini, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.3607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3607
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Radiation therapy (RT) with concomitant capecitabine and celecoxib followed by surgery in patients with locally advanced cancer of the rectums:: A phase II study
    Kouri, M.
    Huuhtanen, R.
    Joensuu, T.
    Osterlund, F.
    Tenhunen, M.
    Luukkonen, P.
    Joensuu, H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 190 - 191
  • [32] Phase 1/2 Study of Mocetinostat and Durvalumab (MEDI4736) in Patients with Advanced Solid Tumors and Non Small Cell Lung Cancer (NSCLC)
    Haigentz, Missak
    Nemunaitis, John
    Johnson, Melissa
    Mohindra, Nisha
    Eaton, Keith
    Patel, Manish
    Awad, Mark
    Faltaos, Demiana
    Chen, Isan
    Christensen, James
    Potvin, Diane
    Neskorik, Tavette
    Levisetti, Matteo
    Garon, Edward
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1073 - S1074
  • [33] A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer
    Natoli, C.
    Cianchetti, E.
    Tinari, N.
    Angelucci, D.
    Grassadonia, A.
    Zilli, M.
    Ficorella, C.
    Ricevuto, E.
    Grossi, S.
    De Tursi, M.
    Carella, C.
    Rispoli, A. I.
    Iacobelli, S.
    ANNALS OF ONCOLOGY, 2007, 18 (06) : 1015 - 1020
  • [34] A phase II study of durvalumab (MEDI4736) for previously treated patients with stage IV squamous NSCLC (SqNSCLC): Lung-MAP Substudy SWOG S1400A
    Papadimitrakopoulou, V.
    Redman, M. W.
    Borghaei, H.
    Waqar, S. N.
    Robert, F.
    Kiefer, G. J.
    McDonough, S.
    Herbst, R. S.
    Kelly, K.
    Gandara, D. R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer
    Lee, Nancy Y.
    Riaz, Nadeem
    Wu, Vanessa
    Brinkman, Thomas
    Tsai, Chiaojung J.
    Zhi, Wanquing
    Fetten, James
    Ho, Alan
    Wong, Richard J.
    Ghossein, Ronald
    Tuttle, Michael
    Fagin, James
    Pfister, David G.
    Sherman, Eric
    THYROID, 2022, 32 (07) : 799 - 806
  • [36] Capecitabine and oxaliplatin as induction and concomitant with radiotherapy in rectal cancer: A phase II study
    Gutierrez, J. A.
    Martinez-Martinez, G.
    Silva, A. J.
    Gomez Rangel, J., Sr.
    Palmerin, M.
    Gutierrez, M.
    Garcia, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [37] Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
    Catherine R. Hanna
    Sean M. O’Cathail
    Janet S. Graham
    Mark Saunders
    Leslie Samuel
    Mark Harrison
    Lynsey Devlin
    Joanne Edwards
    Daniel R. Gaya
    Caroline A. Kelly
    Liz-Anne Lewsley
    Noori Maka
    Paula Morrison
    Louise Dinnett
    Susan Dillon
    Jacqueline Gourlay
    Jonathan J. Platt
    Fiona Thomson
    Richard A. Adams
    Campbell S. D. Roxburgh
    Radiation Oncology, 16
  • [38] Phase II Study of Irinotecan and Capecitabine Concurrent With Intensity Modulated Radiation Therapy in the Treatment of Recurrent Rectal Cancer
    Cai, G.
    Zhang, Z.
    Xu, Y.
    Zhu, J.
    Hu, W.
    Gu, W.
    Cai, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S194 - S195
  • [39] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
  • [40] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    ANGIOGENESIS, 2012, 15 (01) : 141 - 150
12345